U.S. Preventive Services Task Force*
Requests for Single Reprints: Reprints are available from the USPSTF Web site (www.preventiveservices.ahrq.gov) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295).
This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for osteoporosis and the supporting scientific evidence and updates the 1996 USPSTF recommendations on this topic. The complete USPSTF recommendation and rationale statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF Web site (www.preventiveservices.ahrq.gov), the National Guideline Clearinghouse (www.guideline.gov), and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358-9295; e-mail, firstname.lastname@example.org). The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the summary of the evidence and the systematic evidence review on the Web sites already mentioned.
*For a list of the members of the U.S. Preventive Services Task Force, see the Appendix.
Appendix Table 1. U.S. Preventive Services Task Force Grades and Recommendations
Appendix Table 2. U.S. Preventive Services Task Force Grades for Strength of Overall Evidence
U.S. Preventive Services Task Force*. Screening for Osteoporosis in Postmenopausal Women: Recommendations and Rationale. Ann Intern Med. 2002;137:526–528. doi: https://doi.org/10.7326/0003-4819-137-6-200209170-00014
Download citation file:
Published: Ann Intern Med. 2002;137(6):526-528.
Endocrine and Metabolism, Guidelines, Metabolic Bone Disorders, Prevention/Screening.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use